Rein Therapeutics Inc (RNTX)

$1.39 +0.26 (23.01%)
Market Cap 32.39M
Revenue (ttm) 0.00
Net Income (ttm) -62.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 644,500
Avg Vol 65,946
Day's Range N/A - N/A
Shares Out 23.31M
Stochastic %K 97%
Beta 1.31
Analysts Hold
Price Target $7.00

Company Profile

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The com...

Industry: Biotechnology
Sector: Healthcare
Phone: 737 802 1989
Address:
12407 N. Mopac Expy., Suite 250 #390, Austin, United States
ahTony
ahTony Aug. 29 at 11:00 PM
$RNTX whats going on here?
0 · Reply
dbr_island
dbr_island Aug. 29 at 10:52 PM
$RNTX there it goes AH SRXH is my next BIG runner 🚨🚨🚨 I want $1 at MINIMUM 🎯✅ WATCH AND LEARN LIKE👇
0 · Reply
lrak02
lrak02 Aug. 29 at 10:51 PM
$RNTX what
0 · Reply
rapture_iscoming
rapture_iscoming Aug. 29 at 7:24 PM
$RNTX last chance to enter before $10
0 · Reply
JarvisFlow
JarvisFlow Aug. 19 at 2:18 PM
Brookline Capital has updated their rating for Rein Therapeutics ( $RNTX ) to Hold.
0 · Reply
jcooptechit
jcooptechit Aug. 8 at 4:53 PM
$RNTX is revolutionizing cancer care! 🔹 FDA-cleared RenovoCath targets tumors with precision. 🔹 13 top cancer centers on board. 🔹 Phase III trial nears completion. 🔹 Analysts call it undervalued. Big milestones ahead! https://www.tipranks.com/news/the-fly/meet-renovorx-fly-exclusive-interview-with-ceo-shaun-bagai-thefly
0 · Reply
jcooptechit
jcooptechit Aug. 7 at 5:41 AM
Current Focus List: 🧐 - CAN - PROP - IPA - KODK - $RNTX - $WINT - $AIMD - $BINI ~ Traders Hub
0 · Reply
Majid74
Majid74 Aug. 2 at 12:01 PM
$RNTX https://ir.reintx.com/news-releases/news-release-details/rein-therapeutics-enters-agreements-21-million-flexible
0 · Reply
Majid74
Majid74 Aug. 2 at 9:14 AM
$RNTX News??
0 · Reply
Aburose
Aburose Aug. 1 at 10:35 PM
$RNTX next week target between 12-15
2 · Reply
Latest News on RNTX
Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Aug 19, 2025, 8:00 AM EDT - 12 days ago

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025

Aug 14, 2025, 5:00 PM EDT - 17 days ago

Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025

Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Jun 24, 2025, 10:11 AM EDT - 2 months ago

Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders

US FDA puts on hold Rein Therapeutics' lung disease drug trial

Jun 12, 2025, 5:18 PM EDT - 2 months ago

US FDA puts on hold Rein Therapeutics' lung disease drug trial

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

May 27, 2025, 7:00 AM EDT - 3 months ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

IQV

Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference

May 19, 2025, 4:51 PM EDT - 3 months ago

Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference

Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025, 4:09 PM EDT - 3 months ago

Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF

May 12, 2025, 7:00 AM EDT - 3 months ago

Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

May 1, 2025, 7:00 AM EDT - 4 months ago

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025

Apr 30, 2025, 4:05 PM EDT - 4 months ago

Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025

Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference

Apr 28, 2025, 7:00 AM EDT - 4 months ago

Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference

Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases

Apr 23, 2025, 7:00 AM EDT - 4 months ago

Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases

Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F

Apr 15, 2025, 7:00 AM EDT - 4 months ago

Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F

Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Apr 7, 2025, 4:17 PM EDT - 5 months ago

Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

ahTony
ahTony Aug. 29 at 11:00 PM
$RNTX whats going on here?
0 · Reply
dbr_island
dbr_island Aug. 29 at 10:52 PM
$RNTX there it goes AH SRXH is my next BIG runner 🚨🚨🚨 I want $1 at MINIMUM 🎯✅ WATCH AND LEARN LIKE👇
0 · Reply
lrak02
lrak02 Aug. 29 at 10:51 PM
$RNTX what
0 · Reply
rapture_iscoming
rapture_iscoming Aug. 29 at 7:24 PM
$RNTX last chance to enter before $10
0 · Reply
JarvisFlow
JarvisFlow Aug. 19 at 2:18 PM
Brookline Capital has updated their rating for Rein Therapeutics ( $RNTX ) to Hold.
0 · Reply
jcooptechit
jcooptechit Aug. 8 at 4:53 PM
$RNTX is revolutionizing cancer care! 🔹 FDA-cleared RenovoCath targets tumors with precision. 🔹 13 top cancer centers on board. 🔹 Phase III trial nears completion. 🔹 Analysts call it undervalued. Big milestones ahead! https://www.tipranks.com/news/the-fly/meet-renovorx-fly-exclusive-interview-with-ceo-shaun-bagai-thefly
0 · Reply
jcooptechit
jcooptechit Aug. 7 at 5:41 AM
Current Focus List: 🧐 - CAN - PROP - IPA - KODK - $RNTX - $WINT - $AIMD - $BINI ~ Traders Hub
0 · Reply
Majid74
Majid74 Aug. 2 at 12:01 PM
$RNTX https://ir.reintx.com/news-releases/news-release-details/rein-therapeutics-enters-agreements-21-million-flexible
0 · Reply
Majid74
Majid74 Aug. 2 at 9:14 AM
$RNTX News??
0 · Reply
Aburose
Aburose Aug. 1 at 10:35 PM
$RNTX next week target between 12-15
2 · Reply
Aburose
Aburose Aug. 1 at 10:23 PM
$RNTX Rein Therapeutics Enters Into Two Strategic Financing Agreements With Affiliate Of Yorkville Advisors Global, Providing Potential For Access To Up To $21M In Capital
0 · Reply
dbr_island
dbr_island Aug. 1 at 10:17 PM
There goes $RNTX VCIG is my next one Here’s why👇
0 · Reply
jcooptechit
jcooptechit Jul. 31 at 2:08 PM
Revolutionary Biotech Targeting Pancreatic Cancer. $RNTX has a 700%+ Upside Potential! 🔸FDA-cleared RenovoCath delivers 100x tumor exposure with less toxicity. 🔸TIGeR-PaC shows data of a 6-month survival boost and in Phase III. 🔸Analysts are bullish, projecting price targets up to $12. 🔸Backed by a solid $7.1M cash runway, no dilution risk, and insider buying. Communicated - Disclaimer https://stockresearchtoday.com/delivering-therapy-where-it-matters/
0 · Reply
Tunes444
Tunes444 Jul. 30 at 1:42 PM
$RNTX my thoughts exactly.
0 · Reply
DarcyF
DarcyF Jul. 30 at 1:24 PM
$RNTX
0 · Reply
MagelaMason
MagelaMason Jul. 30 at 1:23 PM
$RNTX Financing is for sure going to keep the lights on for next little while. Hopefully they can get some good results and keep the momentum going forward.
0 · Reply
LondonLeaves9845
LondonLeaves9845 Jul. 30 at 1:21 PM
$RNTX's pipeline is focused entirely on serious, high-barrier pulmonary conditions
0 · Reply
PaoloWorld
PaoloWorld Jul. 30 at 1:20 PM
The 36-month SEPA window gives $RNTX some flexibility.
0 · Reply
StayinOuttaTheRed
StayinOuttaTheRed Jul. 30 at 1:20 PM
$RNTX
0 · Reply
Tester87100
Tester87100 Jul. 30 at 1:17 PM
$RNTX this is for sure going to keep the lights on for a while, whats their burn rate?
0 · Reply
Fearrr
Fearrr Jul. 30 at 1:16 PM
$RNTX Just saw UVI drop a video on these guys
0 · Reply
Viiinnkkaa
Viiinnkkaa Jul. 30 at 1:14 PM
$RNTX Following this one!
0 · Reply